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Eukaryotic gene expression is constantly controlled by the translation-coupled nonsense-
mediated mRNA decay (NMD) pathway. Aberrant translation termination leads to NMD
activation, resulting in phosphorylation of the central NMD factor UPF1 and robust clearance
of NMD targets via two seemingly independent and redundant mRNA degradation branches.
Here, we uncover that the loss of the first SMG5-SMG7-dependent pathway also inactivates
the second SMG6-dependent branch, indicating an unexpected functional connection
between the final NMD steps. Transcriptome-wide analyses of SMG5-SMG7-depleted cells
confirm exhaustive NMD inhibition resulting in massive transcriptomic alterations. Intrigu-
ingly, we find that the functionally underestimated SMG5 can substitute the role of SMG7
and individually activate NMD. Furthermore, the presence of either SMG5 or SMG7 is suf-
ficient to support SMG6-mediated endonucleolysis of NMD targets. Our data support an
improved model for NMD execution that features two-factor authentication involving UPF1
phosphorylation and SMG5-SMG7 recruitment to access SMG6 activity.
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Error-free and precisely regulated gene expression is anessential prerequisite for all living organisms. In eukaryotes,transcription and translation are controlled and fine-tuned
by diverse mechanisms to ensure the generation of flawless RNAs
and proteins1. Mature mRNAs that have completed all co-
transcriptional and post-transcriptional processing steps and
passed the associated quality checks are translated into proteins as
the final step of gene expression in the cytoplasm. At this point,
translation-coupled mechanisms inspect the mRNA one last time
to perform final quality control. Specifically, it is assessed whether
the translated mRNAs are legitimate or contain features indicating
that these transcripts encode non-functional, incomplete, or
potentially harmful proteins and therefore have to be degraded2,3.
The arguably most famous translation-coupled quality control
process is nonsense-mediated mRNA decay (NMD), which is best
known for its role to remove mutated transcripts containing a
premature termination codon (PTC)4. However, the relevance
of NMD for cellular maintenance goes beyond the quality
control function and is not restricted to mutated transcripts5.
Previous studies found that about 5–10% of the expressed genes
are affected by NMD in different organisms6–15, suggesting that
NMD serves as a regulatory mechanism, which fine-tunes general
gene expression and helps to minimize the production of aberrant
transcript isoforms. Furthermore, defects in the core NMD
machinery are not compatible with life in higher eukaryotes16–22,
underlining the importance of NMD to function properly during
development and cellular maintenance.
In general, inefficient translation termination seems to be the
primary stimulus for NMD initiation4. Recent evidence suggests
that NMD can in principle be triggered by each translation ter-
mination event with a certain probability23. In higher eukaryotes,
this probability can be modulated by different NMD-activating
features, such as a long 3’ untranslated region (UTR)24–27. How-
ever, the exact length and composition of an NMD-activating 3’
UTR is not exactly defined and many mRNAs contain NMD-
suppressing sequences that allow them to escape this type of
NMD28–30. Another potent activator of NMD is the presence of an
RNA-binding protein complex called the exon-junction complex
(EJC) downstream of a terminating ribosome24,31–37. The EJC
serves as a mark for successful splicing and is deposited onto the
mRNA approximately 20–24 nucleotides upstream of spliced
junctions38–41. Stop codons are typically located in the last exon
of regular protein-coding transcripts, thus ribosomes usually dis-
place all EJCs from a translated mRNA, effectively removing the
degradation-inducing feature. However, mutations or alternative
splicing may produce isoforms with stop codons situated upstream
of EJC deposition sites. Translation of these transcripts would
fail to remove all EJCs and subsequently triggers the decay of the
mRNA via efficiently activated NMD.
Intensive research over several decades uncovered the central
players of the complex NMD pathway and how they cooperate
to achieve highly specific and efficient mRNA degradation.
According to generally accepted models, NMD execution requires
a network of factors to identify a given translation termination
event as aberrant42. The RNA helicase UPF1 holds a central
position in the NMD pathway, as it serves as a binding hub for
other NMD factors and is functionally involved in all stages from
the recognition of NMD substrates until the disassembly of the
NMD machinery43. In translation-inhibited conditions, UPF1 has
the potential to bind non-specifically to all expressed transcripts.
However, in unperturbed cells, UPF1 is found preferentially in the
3′ UTR region of translated mRNA due to the displacement from
the 5′ UTR and coding region by translating ribosomes44–47.
Furthermore, the ATPase and helicase activity of UPF1 is required
to achieve target discrimination, resulting in increased binding of
NMD-targets and release of UPF1 from non-target mRNAs48.
If the translated mRNA contains a premature or otherwise
aberrant termination codon, the downstream bound UPF1 pro-
motes the recruitment of NMD factors and their assembly into an
NMD-activating complex. Subsequently, protein-protein interac-
tions between UPF1, UPF2, UPF3B, and—if present—the EJC
stimulates the phosphorylation of (S/T)Q motifs in UPF1 by the
kinase SMG149–53. Importantly, the activity of the kinase SMG1 is
regulated by multiple accessory NMD factors, presumably to pre-
vent unwanted UPF1 phosphorylation on non-NMD targets54–58.
The continued presence of UPF1 on the target transcript in an
NMD-activating environment leads to gradually increasing hyper-
phosphorylation of UPF1 at up to 19 potential phosphorylation
sites59. The progressively phosphorylated residues in the N-
terminal and C-terminal tails of UPF1 then act as binding sites
for the decay-inducing factors SMG5, SMG6, and SMG760. In this
basic model, hyper-phosphorylation of UPF1 represents a “point of
no return” for NMD activation, which effectively sentences the
mRNA for degradation61.
The final execution of NMD is divided into two major branches.
The first branch relies on the interaction of phosphorylated UPF1
with the heterodimer SMG5-SMG7, which in turn recruits the
CCR4-NOT deadenylation complex62–64. Consequently, SMG5-
SMG7 promote target mRNA deadenylation, followed by decapping
and 5′–3′ or 3′–5′ exonucleolytic degradation65,66. The second
branch is mediated by the endonuclease SMG6, which interacts with
UPF1 to cleave the NMD-targeted transcript in a region around the
NMD-activating stop codon36,67–71. This endonucleolytic cleavage
results in the generation of two decay intermediates, which are
rapidly removed by exonucleolytic decay. Both SMG5-SMG7 and
SMG6-mediated degradation pathways are considered to be
redundant, as they target the same transcripts14. They are also
regarded as independent because downregulation of individual fac-
tors (SMG5, SMG6, or SMG7) only partially inhibits NMD35,62,72.
However, loss of SMG6 impaired NMD more severely than inacti-
vation of SMG7, suggesting that endonucleolytic cleavage is the
preferred decay pathway, whereas deadenylation has merely a
backup/supplementary function14,35,62,70,71,73. Nonetheless, the
apparent redundancy hampered a detailed investigation of the final
steps of NMD so far, since the inactivation of one decay route
seemed to be partially compensated by the other.
Here, we addressed the central question if and how SMG5-
SMG7 and SMG6 functionally cooperate and influence each other.
We hypothesized that the inactivation of SMG5-SMG7 should
activate the SMG6-dependent NMD pathway and still permit
normal NMD if both pathways are independent. However, we
show here that the combined loss of SMG5-SMG7 efficiently
inactivates NMD and that SMG6 was catalytically inactive in cells
depleted of SMG5-SMG7. This demonstrates that SMG6 is not
independent of SMG5-SMG7 and could not compensate for their
loss. This was especially surprising given that SMG6 was pre-
viously considered to be the dominant NMD-executing factor.
Exploring the potential mechanism, we find that SMG7 requires
the interaction with SMG5 and phosphorylated UPF1 for full
NMD activity, whereas SMG5 supports NMD even in the absence
of SMG7. We propose a model, in which either individual or
combined SMG5 and SMG7 recruitment to hyper-phosphorylated
UPF1 acts as an additional licensing step required for SMG6-
mediated degradation of the target transcript. This model of two-
factor authentication explains the tight control of NMD on regular
transcripts, which prevents the untimely access of endonucleolytic
decay activities.
Results
NMD is impaired in SMG7 knockout cells. Phosphorylation of
UPF1 represents a central checkpoint in NMD, which is followed
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by SMG6-mediated endonucleolytic cleavage and/or SMG5-
SMG7-mediated deadenylation of the target transcript (Fig. 1a).
We hypothesized that after deactivating the deadenylation-
dependent NMD branch, the execution of NMD would rely
exclusively on the activity of SMG6. To achieve this goal, we
generated SMG7 knockout (KO) Flp-In-T-REx-293 cells and
identified three clones lacking the SMG7-specific band in western
blot analyses using three different antibodies (Fig. 1b and
Extended Data Fig. 1a, b). In all clones, the SMG7 genomic locus
contained different frame-shift-inducing insertions/deletions,
which also resulted in altered splicing of the CRISPR-targeted
SMG7 exon. (Extended Data Fig. 1c–e). Phenotypically, the
SMG7 KO clones proliferated slower compared to the wild-type
(WT) cells, with no apparent decrease in cell survival (Extended
Data Fig. 1f). These results indicate that the depletion of full-
length SMG7 protein impairs cellular fitness, presumably due to
reduced NMD capacity. To test if NMD is indeed impaired in
SMG7 KO cells, we quantified the levels of two exemplary
endogenous NMD targets. SRSF2 is a serine/arginine-rich (SR)
splicing factor, which auto-regulates its expression by generating
NMD-sensitive splice isoforms of its mRNA74. ZFAS1 is a
snoRNA host mRNA with a short PTC-containing ORF, which
was reported as an NMD target undergoing SMG6-dependent
endocleavage70. In the tested SMG7 KO clones (2 and 34) the
levels of the NMD-sensitive SRSF2 isoforms and the ZFAS1
mRNA were markedly upregulated (Fig. 1c). Baseline levels of
these NMD substrates were restored by expressing the WT SMG7
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NMD defect was quantitatively more pronounced in the SMG7
KO cells compared to a siRNA-mediated knockdown (KD) of
SMG7 in control cells (Fig. 1d).
To gain insights into the transcriptome-wide effects of the
SMG7 depletion, we sequenced poly(A)+ enriched mRNA from
both SMG7 KO clones and identified differentially expressed
genes (Extended Data Fig. 2a and Supplementary Data 1).
Consistent with the mRNA-degrading function of SMG7 in
NMD, more than twice as many genes were upregulated than
downregulated in the SMG7 KO cells (Extended Data Fig. 2b).
Compared to a recently published study using SMG7 KD in HeLa
cells14, this ratio of upregulated vs. downregulated genes was
higher (Extended Data Fig. 2b–e). We observed a substantial
overlap between upregulated genes in both SMG7 KO cell lines,
indicating that these genes are high-confidence SMG7 targets. In
contrast, only a limited overlap between downregulated genes
could be detected, suggesting these are rather clone-specific
effects or off-targets (Extended Data Fig. 2b). From these
analyses, we conclude that the KO of SMG7 leads to stronger
NMD inhibition than the KD.
Next, we quantified alternative splicing events (Supplementary
Data 2), as well as differential transcript usage, and identified
significant isoform switches (Extended Data Fig. 2a and
Supplementary Data 3). Isoform switches are characterized by
significant changes in the relative contribution of isoforms to the
overall gene expression when comparing two conditions75.
Because of the identification at the isoform level, this approach
allows the identification of PTC-containing transcripts that are
upregulated upon NMD inhibition. As a specific example of such
an isoform switch, we visualized the read coverage for the
previously used bona fide NMD target SRSF2. While the overall
SRSF2 expression remained nearly unchanged, we detected
prominent NMD-inducing exon inclusion and 3′ UTR splicing
events in the SMG7 KO but not in the SMG7 KD conditions
(Fig. 1e). We verified the SMG7-dependent upregulation of
additional examples by end-point PCR (Extended Data Fig. 2f–h).
On a transcriptome-wide scale, NMD-sensitive isoforms with
annotated PTC were almost exclusively detected to be upregu-
lated in the SMG7 KO cells, which was not the case in the SMG7
KD in HeLa cells14 (Fig. 1f–i). Collectively, the RNA-Seq data
analysis supported the initial observation that NMD is markedly
impaired when SMG7 is knocked out. Due to the clear effect on
NMD upon complete loss of SMG7, the KO cells provide an ideal
background to examine further mechanistic details of NMD,
which could not be studied before.
SMG5 is required to maintain residual NMD in SMG7-
depleted cells. We utilized the SMG7 KO cells to investigate
which domains and protein-protein interactions of SMG7 are
required to support NMD. Specifically, we aimed to confirm
whether the SMG5-SMG7 heterodimer initially binds phos-
phorylated UPF1 (p-UPF1) and subsequently triggers dead-
enylation of the target mRNA via the recruitment of the CCR4-
NOT complex (Fig. 1a). To this end, we generated stable SMG7
KO clone 2 cell lines that inducibly express SMG7 variants as
rescue proteins. The 14-3-3mut was expected to be inactive in
this assay due to the lack of interaction with UPF1 and p-UPF1
(Fig. 2a–c)76. However, the SMG7 14-3-3mut protein efficiently
restored NMD activity in the SMG7 KO cells (Fig. 2d). This
suggests that the p-UPF1 binding is not absolutely critical for
the function of SMG7 in NMD. Next, we investigated if SMG7
has to form a heterodimer with SMG5 for full NMD activity.
Surprisingly, the expression of a G100E mutant of SMG7
(unable to interact with SMG5; Fig. 2a–c)62 failed to rescue the
NMD defect (Fig. 2d). This finding was unexpected in the light
of the currently advocated NMD model, in which SMG5 is
merely a companion for SMG7 with the role to potentially
strengthen the binding of the SMG5-SMG7 heterodimer to p-
UPF162. This finding prompted us to systematically address the
question, which combinations of the three decay-inducing
proteins SMG5, SMG6, and SMG7 are required for NMD
(Fig. 2e and Extended Data Fig. 3a, b). Single SMG5 or SMG7
KDs in WT 293 cells resulted in very mild or nearly undetect-
able inhibition of NMD, whereas depletion of SMG6 showed an
intermediate effect, reflected by the upregulation of the SRSF2
NMD isoform and ZFAS1 (Fig. 2e and Extended Data Fig. 3b).
Co-depletion of SMG6 and SMG5 via siRNAs showed a similar
inhibitory effect on NMD as the single SMG6 KD (Fig. 2e and
Extended Data Fig. 3b; lane 5 vs. lane 3). As expected, KD of
SMG6 in the SMG7 KO cells strongly abolished NMD activity,
Fig. 1 SMG7 depletion impairs NMD activity. a Schematic representation of the final steps of nonsense-mediated mRNA decay (NMD). Phosphorylated
UPF1 (indicated by the blue sphere) recruits the SMG5-SMG7 heterodimer to the target mRNA (indicated in dark gray), thereby promoting deadenylation
via the CCR4-NOT complex. Recruitment of SMG6 to UPF1 results in endonucleolytic cleavage of the target transcript via the activity of the SMG6 PIN
domain. The SMG5 PIN domain is catalytically inactive. b Western blot analysis of SMG7 knockout (KO) cell lines (clones 2, 31, and 34) with the anti-
SMG7 antibodies AK-133, AK-134, and AK-136 (n= 1); Tubulin serves as control (see “Methods” section and Supplementary Data 6 for antibody details).
The region of SMG7 detected by the antibodies is schematically depicted and the crRNA targeting site indicated. Asterisks indicate non-specific bands.
c End-point RT-PCR detection of SRSF2 transcript isoforms (top) and quantitative RT-PCR-based detection (qPCR; bottom) of ZFAS1 in the indicated cell
lines with or without expression of FLAG-tagged SMG7 as rescue construct. The detected SRSF2 isoforms are indicated on the right, the NMD-inducing
included exon is marked in red (e= exon). Relative mRNA levels of SRSF2 isoforms were quantified from bands of agarose gels (n=3 biologically
independent samples). The ratio of ZFAS1 to the C1orf43 reference was calculated; data points and means from the qPCRs are plotted as log2 fold change
(log2FC) (n= 3 biologically independent samples). The plotted points are color-coded based on cell line (gray=WT; blue= SMG7 KO-2; green= SMG7
KO-34). d Quantitative RT-PCR-based detection (qPCR) of SRSF2 isoforms and ZFAS1 in the indicated cell lines upon treatment with the indicated siRNA.
The ratio of NMD isoform to canonical isoform (SRSF2) and ZFAS1 to the C1orf43 reference was calculated; data points and means from the qPCRs are
plotted as log2 fold change (log2FC) (n= 3 biologically independent samples). e Read coverage of SRSF2 from SMG7 KO and published SMG7 KD (GEO:
GSE86148) RNA-Seq data is shown as Integrative Genomics Viewer (IGV) snapshots. The canonical and NMD-sensitive isoforms are schematically
indicated below. Percent spliced in (PSI; from LeafCutter analysis) and mean counts from 4 indicative splice junctions are shown. Differential gene
expression (from DESeq2) is depicted as log2 fold change (log2FC) in the last column. f Overlap of upregulated or downregulated premature termination
codon (PTC)-containing isoforms between the SMG7 KO or KD RNA-Seq data is shown as UpSet plot. g–i Volcano plots showing the differential transcript
usage (via IsoformSwitchAnalyzeR) in various SMG7 depletion RNA-Seq data. Isoforms containing GENCODE (release 33) annotated PTC (red, TRUE),
regular stop codons (blue, FALSE), or having no annotated open reading frame (gray, NA) are indicated. The change in isoform fraction (dIF) is plotted
against the −log10 adjusted p-value (adj.p-value). Density plots show the distribution of filtered isoforms in respect to the dIF, cutoffs were |dIF|> 0.1 and
adj.p-value < 0.05. P-values were calculated by IsoformSwitchAnalyzeR using a DEXSeq-based test and corrected for multiple testing using the Benjamini-
Hochberg method.
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since both endonucleolytic and exonucleolytic pathways of
NMD are inactivated (Fig. 2e and Extended Data Fig. 3b; lane 8).
Remarkably and contrary to current NMD models, an even
stronger NMD inhibition was observed when depleting SMG5 in
the SMG7 KO cells, which was not further enhanced by the
additional KD of SMG6 (Fig. 2e and Extended Data Fig. 3b; lane
9 vs. lane 7). This unanticipated result can explain our obser-
vation of why the SMG7 G100E mutant does not rescue the
SMG7 KO and indicates that the SMG5-SMG7 heterodimer is
critical for NMD, even when SMG6 is present. Moreover, these
results expose a previously underestimated critical role of SMG5






















































1 2 3 4 56















































1 2 3 4 5



































1 2 3 4 5 6











































































































Fig. 2 SMG7 requires interaction with SMG5 to rescue the SMG7 knockout phenotype. a Schematic representation of the SMG7 domain structure on the
left. The proposed functions of the domains are indicated and mutated constructs and their expected effect are shown below. The illustration on the right
depicts which mutation is expected to impair which individual SMG7 function and/or protein-protein interaction. bModel of the SMG5-SMG7 heterodimer
structure. Human SMG7 (PDB ID: 1YA0) was modeled on the C. elegans SMG5-SMG7 structure (PDB ID: 3ZHE). Critical SMG7 mutations are highlighted
in red and the indicated sulfate ion mimics a phosphorylated residue. c Western blot after FLAG co-immunoprecipitation (IP) of FLAG-tagged GST
(control) or SMG7 constructs in SMG7 KO cells (n= 1). Tubulin serves as a control. d Quantitative RT-PCR-based detection (qPCR) of SRSF2 isoforms and
ZFAS1 was carried out in the indicated cell lines upon expression of the indicated FLAG-tagged rescue constructs. The ratio of NMD isoform to canonical
isoform (SRSF2) and ZFAS1 to the C1orf43 reference was calculated; data points and means from the qPCRs are plotted as log2 fold change (log2FC)
(n= 3 biologically independent samples). Rescue efficiency was calculated based on the mean log2FC in relation lane 1 (set to 1) and lane 2 (set to 0).
Western blot analyses are shown below (n= 1). Tubulin serves as a control. e Heatmap of quantitative RT-PCR-based detection (qPCR) of SRSF2 isoforms
and ZFAS1 in the indicated cell lines upon treatment with the indicated siRNA. The ratio of NMD isoform to canonical isoform (SRSF2) and ZFAS1 to the
C1orf43 reference was calculated; mean log2 fold change (log2FC) is shown (n= 3 biologically independent samples). The corresponding individual data
points are plotted in Extended Data Fig. 3b. f Heatmap of quantitative RT-PCR-based detection (qPCR) of SRSF2 isoforms in the indicated cell lines upon
treatment with the indicated siRNA and expression of the indicated FLAG-tagged rescue constructs. The ratio of NMD isoform to canonical isoform
(SRSF2) was calculated; mean log2 fold change (log2FC) is shown (n= 3 biologically independent samples). The corresponding individual data points are
plotted in Extended Data Fig. 3c. Clustering (k= 3) and functional summary of SMG7 mutations for NMD activity are depicted below.
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To gain further mechanistic insight into the cooperation
between SMG5, SMG6, and SMG7, we performed complementa-
tion experiments in SMG7 KO cells with additional SMG7 rescue
constructs and in combination with SMG5 or SMG6 KDs
(Extended Data Fig. 3c). Three main clusters of rescue conditions
were identified according to their NMD activity (Fig. 2f and
Extended Data Fig. 3d). Consistent with our earlier observations,
SMG7 WT rescued the SMG7 defect in all conditions and
restored high NMD activity. The SMG7 1-633 deletion mutant
(reported to be unable to recruit the CCR4-NOT complex;
Fig. 2a)64 also conferred high NMD activity in SMG7 KO cells,
even when SMG5 or SMG6 were depleted in addition (Fig. 2f and
Extended Data Fig. 3c, d). This result indicates that the
accelerated deadenylation of NMD substrates by SMG7-
recruited CCR4-NOT is not required for their efficient degrada-
tion. In contrast to a previous report64, the C-terminus of SMG7
is not required for NMD even when SMG6 is downregulated.
However, by combining the C-terminal truncation with either 14-
3-3mut or G100E mutations, these SMG7 variants became less
NMD-competent, especially in the SMG5 KD condition (Fig. 2f
and Extended Data Fig. 3c, d). This observation suggests that the
deadenylation-inducing activity might serve as an additive but
dispensable feature that helps to clear NMD targets, especially
when other features of SMG7 are inactivated. In the full-length
SMG7 context, the 14-3-3mut or G100E mutations displayed
intermediate NMD rescue activity in the SMG5 and SMG6 KD
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conditions, whereas a 14-3-3mut/G100E double-mutation was
completely inactive in all conditions (Fig. 2f and Extended Data
Fig. 3d). All KD/rescue experiments were also performed in the
SMG7 KO clone 34 and showed similar functional outcomes
(Extended Data Fig. 3e). In summary, these results reveal the
synergistic effect of simultaneous binding of SMG7 to p-UPF1
and SMG5, whereas the lack of both interactions incapacitates the
function of SMG7 in NMD.
Next, we performed co-immunoprecipitation (co-IP) experi-
ments with the functionally tested set of FLAG-tagged SMG7
constructs to analyze their steady-state interaction with UPF1
(Extended Data Fig. 3f). The full-length or truncated 14-3-3mut
SMG7 protein showed strongly impaired ability to co-
immunoprecipitate UPF1, consistent with the role of the 14-3-
3-like domain to mediate the stable interaction with phosphory-
lated UPF1 (Extended Data Fig. 3f; lane 10 vs. lanes 11 and
15)63,77. In turn, this result also indicates that SMG5 does not
bridge the 14-3-3mut SMG7 protein to UPF1. The G100E mutants
co-immunoprecipitated similar UPF1 levels than the respective
WT construct (Extended Data Fig. 3f; lanes 10,14 vs. lanes 12,16),
confirming that SMG7 does not require the heterodimerization
with SMG5 to interact with UPF162. In conjunction with the
impaired functional rescue of the G100E mutants (Fig. 2f and
Extended Data Fig. 3c–e), this result implies that disrupting the
interaction of SMG7 with SMG5 impairs NMD even when the
interaction between SMG7 and UPF1 is maintained. In conclu-
sion, our functional studies reveal the previously underestimated
requirement for SMG7 to interact with both p-UPF1 and SMG5
in order to support full NMD activity.
SMG5 functionally complements the loss of SMG7. The unex-
pected relevance of SMG5 prompted us to investigate the mole-
cular properties of SMG5 in more detail. Similar to our analysis of
SMG7, we aimed to understand which functions of SMG5 are
required to maintain NMD competence in the presence or
absence of SMG7. The first striking result was the almost com-
plete rescue of the SMG7 depletion phenotype by the over-
expression (~50-fold) of SMG5 WT or G120E mutant (reduced
interaction with SMG7)62 in control or SMG5 KD conditions
(Fig. 3a, b and Extended Data Fig. 4a–c). This finding was very
surprising since SMG5 is not expected to be able to directly carry
out RNA degradation. Although SMG5 harbors a PilT N-
terminus (PIN) domain that structurally resembles the functional
PIN domain of SMG6, two of the three required catalytic residues
are missing in the inactive C-terminal SMG5 PIN domain
(Fig. 3a)78. SMG5 was found in one study to promote degradation
by interacting with the decapping factor PNRC2 (Fig. 3a), which
could explain the NMD activity we observe in the rescue assays79.
However, we did not observe any effects of PNRC2 KDs on the
ability of SMG5 to rescue the NMD defects (Fig. 3c), consistent
with other studies which failed to confirm this PNRC2-dependent
path of SMG5-dependent degradation64,65.
Collectively, the observation of SMG5 expression rescuing
SMG7 loss once again calls into question the relevance of the
SMG7 deadenylation-promoting function for NMD. We
hypothesized that in the absence of SMG7, SMG5 interacts with
p-UPF1 via its N-terminal 14-3-3-like domain to activate NMD.
In line with this hypothesis, mutating three residues in the
potential phosphopeptide binding pocket of SMG5 severely
affected the ability of SMG5 to rescue the SMG7 KO phenotype
in control or SMG5 KD conditions (Fig. 3b and Extended Data
Fig. 4a, b). Of note, we could not detect any stable binding of
SMG5 to UPF1 above background levels in SMG7 KO cells
(Extended Data Fig. 4d), confirming that strong SMG5-UPF1
interactions require SMG7. However, in WT cells the 14-3-3mut
SMG5 protein showed reduced binding to p-UPF1 (Fig. 3d).
We hypothesized that besides the interaction with UPF1
another function of SMG5 may be required to maintain NMD
activity. To test this idea, we generated an SMG5 deletion mutant
(1-853) lacking the C-terminal PIN domain (Fig. 3a). This SMG5
mutant, albeit being able to interact with UPF1 (Fig. 3d), was
unable to restore NMD activity (Fig. 3b and Extended Data
Fig. 4a, b), suggesting that the catalytically inactive PIN domain
of SMG5 carries out an essential function during NMD. In search
of an explanation, we considered earlier reports that the C-
terminus of SMG5 is involved in the dephosphorylation of UPF1,
likely by direct recruitment of the protein phosphatase 2 (PP2A)
complex (Fig. 3a)53,60. Appropriately, we observed that the
expression of the SMG5 1-853 construct leads to overall increased
UPF1 phosphorylation, and consequently the SMG5 1-853
protein co-immunoprecipitated more p-UPF1 (Fig. 3d), indicat-
ing that the C-terminal PIN domain could play a role in
the dephosphorylation of UPF1. To address whether the
SMG5 PIN domain indeed enables the dephosphorylation of
UPF1 via the direct recruitment of PP2A, we performed co-
immunoprecipitation of FLAG-tagged SMG5 WT or 1-853
constructs in WT 293 cells, followed by label-free mass spectro-
metry (Supplementary Data 4). Although both SMG5 constructs
Fig. 3 SMG5 expression rescues the SMG7 KO phenotype. a Schematic representation of the SMG5 domain structure on the left. The proposed functions
of the domains are indicated and mutated constructs and their expected effect are shown below. The illustration on the right depicts which mutation is
expected to impair which individual SMG5 function and/or protein-protein interaction. b Heatmap of quantitative RT-PCR-based detection (qPCR) of
SRSF2 isoforms in the indicated cell lines upon treatment with the indicated siRNA and expression of the indicated FLAG-tagged rescue constructs. The
ratio of NMD isoform to canonical isoform (SRSF2) was calculated; mean log2 fold change (log2FC) is shown (n= 3 biologically independent samples).
The corresponding individual data points are plotted in Extended Data Fig. 4a. Clustering (k= 3) and functional summary of SMG5 mutations for NMD
activity are depicted below. c Quantitative RT-PCR-based detection (qPCR) of SRSF2 isoforms and ZFAS1 was carried out in the indicated cell lines upon
treatment with the indicated siRNA and expression of the indicated FLAG-tagged rescue constructs. The ratio of NMD isoform to canonical isoform
(SRSF2) and ZFAS1 to the C1orf43 reference was calculated; data points and means from the qPCRs are plotted as log2 fold change (log2FC) (n= 3
biologically independent samples). Rescue efficiency was calculated based on the mean log2FC in relation lane 1 (set to 1) and lane 4 (set to 0). dWestern
blot after FLAG co-immunoprecipitation (IP) of FLAG-tagged GST (control) or SMG5 constructs in WT cells (n= 1). Tubulin serves as a control.
e–g Volcano plots of mass spectrometry-based analysis of the interaction partners of FLAG-tagged SMG5 WT or 1-853 constructs in WT cells (n= 4
biologically independent samples). e SMG5 WT against FLAG control, (f) SMG5 1-853 against FLAG control, (g) SMG5 1-853 against SMG5 WT. The
yellow color labeling indicates targets that are significant in the respective comparisons after two-sided Welch’s t-testing (log2 fold change (log2FC) >1 or
|log2FC| >1; and adj. p-value <0.05). Points labeled in blue indicate phosphatase subunits of interest; points labeled in red indicate NMD factors.
Highlighted proteins that were not significant in the respective comparisons are labeled with gray text. h Analysis of endogenous UPF1 serine 1127 (S1127)
phosphorylation status in the indicated cell lines and knockdown conditions. Quantification results of phosphorylated UPF1 (p-UPF1) vs. total UPF1 are
shown as data points and mean (n= 3 biologically independent samples). Knockdown of SMG5 protein as a western blot (n= 2 biologically independent
samples) and the functional impact on SRSF2 isoform distribution (End-point RT-PCR as in Fig. 1c; n= 3 biologically independent samples) is shown.
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co-immunoprecipitated the direct binding partner SMG7 effi-
ciently, we did not detect a significant enrichment of neither
PP2A nor PP1 protein phosphatase complex components
(Fig. 3e–g). We detected increased levels of UPF1 and UPF2 in
the SMG5 1-853 co-immunoprecipitation compared to the SMG5
WT, whereas PNRC2 or other NMD components such as SMG6
were not enriched in any condition (Fig. 3e–g and Supplementary
Data 4). Collectively, these findings do not provide evidence for
but rather against the direct recruitment of PP2A via the SMG5
PIN domain, which questions the previously assumed role of
SMG5 in UPF1 dephosphorylation. An alternative explanation
could be that the SMG5 PIN domain is critical to promote NMD
execution once SMG5 is bound to p-UPF1. Accordingly, the
absence of the PIN domain would lead to the accumulation of
NMD-incompetent UPF1 complexes. Supporting evidence for
this hypothesis is the failed functional rescue of SMG5 1-853
(Fig. 3b and Extended Data Fig. 4a, b), the increased interaction
with UPF1 and UPF2 (Fig. 3e–g), and the apparent hyper-
phosphorylation of UPF1 (Fig. 3d).
The finding of SMG5-dependent alterations of UPF1 phos-
phorylation levels prompted us to test whether, in cells lacking
either SMG5, SMG7, or both, the general UPF1 phosphorylation
status is changed. These alterations could reflect stalled UPF1-
containing complexes in an arrested NMD processes. To this end,
we expressed FLAG-tagged UPF1 in WT or SMG7 KO cells and
detected its overall S/T phosphorylation level after immunopre-
cipitation (Extended Data Fig. 4e). The overexpressed
UPF1 showed elevated phosphorylation in the SMG7 KO cells,
which were not further increased when SMG5 was depleted
(Extended Data Fig. 4e). We also assessed the SMG5-SMG7
dependent phosphorylation status of endogenous UPF1 using the
phospho-S1127 specific antibody. Whereas the isolated KD of
SMG5 had no effect on the phosphorylation status, similarly
increased p-UPF1/UPF1 ratios were detected in SMG7 KO cells
with or without SMG5 KD (Fig. 3h). Together, this indicates that
the severe NMD defects observed in SMG5-SMG7 depleted cells
compared to SMG7 KO cells do not coincide with further
increased accumulation of hyper-phosphorylated UPF1.
Searching for other possible molecular explanations, we considered
previous reports that SMG5 and SMG7 stabilize p-UPF1 binding to
target mRNAs61 and ATPase-deficient UPF1 mutants accumulate in
a hyper-phosphorylated, SMG5-SMG7 bound state48. Inspired by
these results, we investigated whether the ability of UPF1 to bind to
and/or to recognize NMD targets is impaired in SMG5-SMG7
depleted cells. To this end, we employed UPF1 RNA immunopre-
cipitation (RIP) assays to study NMD target discrimination by
UPF148. Binding of UPF1 to two NMD targets, which displayed
increased mRNA levels upon NMD inhibition (Supplementary
Data 1), as well as to two non-NMD targets remained unchanged
in control, SMG5 KD, SMG7 KO, or SMG7 KO plus SMG5 KD
conditions (Extended Data Fig. 4f–i). These results suggest that UPF1
can identify and bind to NMD-targeted transcripts, although their
degradation cannot be executed anymore.
NMD is severely inhibited transcriptome-wide upon loss of
SMG5-SMG7. The strongly impaired NMD in cells depleted of
SMG5 and SMG7 encouraged us to sequence mRNA from SMG7
KO cells (clones 2 and 34) with an additional SMG5 or SMG6 KD
(Extended Data Fig. 5a). As expected for severe NMD inhibition,
the combined depletion of SMG6 and SMG7 resulted in massive
changes of gene expression and isoform usage, which were qua-
litatively and quantitatively comparable to published SMG6-
SMG7 double KD in HeLa cells14 (Fig. 4a–c and Extended Data
Fig. 5b–d). Whereas SMG5 KD in control cells had very mild
effects on the transcriptome, downregulation of SMG5 in SMG7
KO cells exhibited equal or even more pronounced changes in
gene expression and isoform usage compared to the SMG6-
SMG7-depleted condition (Fig. 4d–f and Extended Data Fig.
5e–g). As a representative example, the alternative splicing pat-
tern of SRSF2 displayed a complete switch from the normal to
NMD-sensitive isoforms when SMG5 or SMG6 were depleted in
SMG7 KO cells (Fig. 4g). Interestingly, the highest overlap of
upregulated NMD-sensitive isoforms was found between both
SMG7 KO cell lines with SMG5 or SMG6 KD, suggesting that
these four conditions predominantly target the same transcripts
(Extended Data Fig. 5h).
Intrigued by the remarkable changes in gene expression and
isoform usage when NMD was effectively inhibited, we wanted to
re-examine the statement that up to 10% of genes are affected by
NMD. To this end, we calculated how many genes showed single
or combined differential gene expression (DGE), differential
transcript usage (DTU), or alternative splicing (AS) events when
the SMG7 KO was combined with the KD of SMG5 or SMG6
(Fig. 4h). With this approach, we find that about 40% of the
expressed genome in the Flp-In-T-REx-293 cells is directly or
indirectly altered by strong NMD inhibition. With more stringent
cutoffs for the analyses, still, around 20% of all expressed genes
were affected (Extended Data Fig. 5i), mostly those with medium
to high expression levels (Extended Data Fig. 5j). Collectively, the
RNA-Seq analysis confirmed that SMG5 KD, as well as SMG6
KD, have similar effects on NMD in SMG7 KO cells. It also
provided global evidence that the loss of the SMG5-SMG7
heterodimer effectively inactivates NMD and leads to massive
changes in the expressed transcriptome. In combination with the
functional studies (Figs. 2–3), these transcriptome-wide observa-
tions profoundly question the independence of the SMG5-SMG7
and SMG6 decay pathways and suggest a functional connection
during NMD execution.
Loss of SMG5 and SMG7 prohibits endonucleolytic cleavage of
NMD substrates. The observed NMD inhibition upon the co-
depletion of SMG5 and SMG7 suggests that SMG6 is equally
inactivated, although it is widely assumed that SMG6 acts
redundantly to and independently of SMG5-SMG714,64. This
unexpected result raised the question, whether SMG6 requires the
presence of SMG5-SMG7 for endonucleolytic cleavage of its
target mRNAs during NMD. We monitored the activity of SMG6
by northern blotting, which allows us to detect decay inter-
mediates resulting from endonucleolytic or 5′–3′ exonucleolytic
degradation. To this end, stably integrated triosephosphate iso-
merase (TPI) mRNA reporters were expressed as WT or NMD-
inducing PTC160 variant in control or SMG7 KO cells with
different combinations of siRNA-mediated knockdowns (Fig. 5a).
The reporter mRNA also contained XRN1-resistant sequences
(xrRNAs) in the 3′ UTR that produce meta-stable intermediates
of 5′–3′ decay (called xrFrag) and thereby provided information
about the extent and directionality of mRNA degradation72,80.
Upon depletion of the major cytoplasmic 5′–3′ exonuclease
XRN1, SMG6-generated endonucleolytic cleavage products
(designated 3′ fragments) of the PTC-containing reporter mRNA
are detected as an additional band (Extended Data Fig. 6a; lane 6).
Of note, the isolated SMG7 KO or SMG6 KD resulted in a slight
accumulation of the full-length reporter (Extended Data Fig. 6a;
lanes 8 and 10), indicating partial NMD inhibition consistent
with the literature and our earlier observations. However, we did
not observe increased 3′ fragment levels upon loss of SMG7,
which indicates that the SMG6 activity is not compensatory in the
absence of SMG7 (Fig. 5b and Extended Data Fig. 6a, b; lane 14).
While KD of SMG5 in control cells had no inhibitory effect on
endonucleolytic cleavage, depletion of SMG5 in SMG7 KO cells
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completely abolished the generation of 3′ fragments (Fig. 5b and
Extended Data Fig. 6b; lanes 4 and 8 vs. 12 and 16). Furthermore,
the accumulation of the PTC160 reporter mRNA to WT levels
and the decrease of the xrFrag band confirmed that NMD is
thoroughly inactivated in SMG5-SMG7-depleted conditions.
The dramatic effect on the endonucleolytic cleavage activity
was further confirmed by investigating the naturally occurring
meta-stable cleavage product of NOP56 (Fig. 5c)81. We used the
NOP56 cleavage product as an indicator for SMG6 activity since
the generation of this meta-stable RNA fragment was shown to
be strongly SMG6-dependent81. In control cells, the cleavage
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the SMG5-SMG7-depleted condition (Fig. 5d). Taken together,
these results underline the previous observation that the SMG5-
SMG7 heterodimer is required for general NMD activity and,
surprisingly, also for SMG6 activity.
Finally, we were intrigued by the fact that both SMG5 and
SMG7 wild-type proteins can individually rescue the SMG7 KO
phenotype. Specifically, we wondered if the main NMD-
supporting function of both factors could be to enable and/or
sustain SMG6-mediated endonucleolytic cleavage of the target
mRNA. All SMG5 and SMG7 rescue proteins that restored full
NMD activity also resulted in a normal NOP56 cleavage pattern,
indicating that SMG6 was reactivated in these cells (Fig. 5d).
Based on these results, we postulate that SMG5 and SMG7
maintain NMD activity by permitting the activation of SMG6.
SMG6 can interact with UPF1 in SMG5-SMG7-depleted cells.
Given the inability of SMG6 to cleave target mRNAs in SMG5-
SMG7 depleted cells, we next investigated the interaction between
SMG6 and UPF1, which we considered central in this context.
Due to the low abundance of SMG6 compared to UPF1 (more
than 100-fold lower; Extended Data Fig. 7a) and the presumably
transient mode of their interaction, the investigation of UPF1-
SMG6 binding in the cellular context has been notoriously dif-
ficult to detect by standard co-IP experiment82. To detect the
transient interaction between SMG6 and UPF1, we used the
TurboID-catalyzed proximity labeling technology83,84 to bioti-
nylate UPF1 binding partners (Fig. 6a). We established stable cell
lines that inducibly expressed FLAG-TurboID (reference con-
struct) or FLAG-TurboID-UPF1 and confirmed the biotinylation
activity of these constructs (Extended Data Fig. 7b). We used
15 min biotin labeling for both TurboID constructs in WT and
SMG7 KO cells upon control or SMG5 KD (Fig. 6b). FLAG-
TurboID-UPF1 displayed prominent self-biotinylation but also
efficiently biotinylated the known binding partner UPF3B in
contrast to the TurboID control (Fig. 6b). Nevertheless, we were
not able to obtain quantitative data regarding the interaction of
SMG6 with UPF1 by western blotting. To overcome this problem,
we turned to the label-free mass spectrometric analysis of the
streptavidin-enriched proteins (Supplementary Data 5). We
detected known UPF1 interacting NMD factors (e.g., UPF3B), but
also other binding partners (e.g., Staufen proteins; STAU1 and
STAU2)85,86, to be enriched in FLAG-TurboID-UPF1-expressing
WT cells, indicating that we indeed captured true UPF1 inter-
action partners (Extended Data Fig. 7d and Supplementary
Data 5). Interestingly, we found in SMG7 KO cells a higher
enrichment of almost all NMD factors, including the NMD
proteins SMG1, SMG6, SMG8, and SMG9, which were not
enriched in WT cells. The enrichment was statistically even more
pronounced with an additional SMG5 KD (Fig. 6c–e and
Extended Data Fig. 7c–f). These findings indicate that UPF1
accumulates together with NMD factors (including SMG6) in
functionally arrested complexes in the absence of SMG5 and
SMG7. Since SMG6 was apparently catalytically inactive in
SMG5-SMG7 depleted cells (Fig. 5), this observed UPF1-SMG6
interaction is likely unproductive and does not represent a
functional NMD complex.
Discussion
The correct execution of NMD not only prevents the production
of aberrant gene products but also shapes the transcriptome on a
global scale43. NMD is generally perceived as a robust, but highly
dynamic process that integrates different inputs, including mRNP
composition and translational status, in order to efficiently
identify and remove transcripts that appear to be faulty42. The
common perception of NMD is that multiple RNA degradation
pathways can be employed after the identification of target
transcripts, which are all centered around the key factor UPF1
and provide reliable elimination of the mRNA. The previously
identified two major decay paths during NMD utilize the UPF1-
recruited SMG5-SMG7 and SMG6. Although evidence pointed to
the independence of these branches in the past, we show here that
SMG6 cannot endonucleolytically cleave NMD substrates in cells
lacking the SMG5-SMG7 heterodimer (Fig. 5 and Extended Data
Fig. 6), resulting in extensive NMD inactivation. Therefore, a
functional dependency between the two pathways exists.
The reason why this dependency has not been detected so far
has probably technical reasons. Virtually all previous experiments
that addressed the interplay between SMG5, SMG6 and SMG7
utilized individual or combined gene silencing of NMD factors
depending on siRNA-mediated or shRNA-mediated knockdown.
As reported before, the downregulation of SMG5 and/or SMG7
by knockdowns only slightly impairs NMD35,62. We show here
that complete and sustained depletion of SMG7 is needed to
detect a considerable NMD defect (Fig. 1 and Extended Data
Fig. 2). Furthermore, the downregulation of SMG5 substantially
affects NMD activity only in the SMG7 KO conditions (Figs. 2, 4
and Extended Data Fig. 5). Therefore, we propose that a con-
ventional downregulation of the SMG5-SMG7 heterodimer is not
sufficient to abolish its function. It was reported before that
SMG5 and SMG7 form stable and long-lived complexes35 and
residual heterodimers could potentially outlive the experimental
timeframe of knockdown experiments. Remarkably, strongly
reduced levels of the SMG5-SMG7 heterodimer after a knock-
down are still able to support NMD, although both proteins are
about two orders of magnitude less abundant than UPF1
(Extended Data Fig. 7a)87–89. This observation indicates that the
basal levels of SMG5 and SMG7 provide enough buffer capacity
to tolerate the partial loss of individual NMD factors or to cope
Fig. 4 Downregulation of SMG5 in SMG7 knockout cells efficiently inactivates NMD. a–f Volcano plots showing the differential transcript usage (via
IsoformSwitchAnalyzeR) in various RNA-Seq data. Isoforms containing GENCODE (release 33) annotated PTC (red, TRUE), regular stop codons (blue,
FALSE), or having no annotated open reading frame (gray, NA) are indicated. The change in isoform fraction (dIF) is plotted against the −log10 adjusted
p-value (adj.p-value). Density plots show the distribution of filtered isoforms in respect to the dIF, cutoffs were |dIF|> 0.1 and adj.p-value <0.05. P-values
were calculated by IsoformSwitchAnalyzeR using a DEXSeq-based test and corrected for multiple testing using the Benjamini-Hochberg method. g Read
coverage of SRSF2 from SMG7 KO and published SMG7 KD (GEO: GSE86148) RNA-Seq data is shown as Integrative Genomics Viewer (IGV) snapshots.
The canonical and NMD-sensitive isoforms are schematically indicated below. Percent spliced in (PSI; from LeafCutter analysis) and mean counts from 4
indicative splice junctions are shown. Differential gene expression (from DESeq2) is depicted as log2 fold change (log2FC) in the last column. h Fraction of
expressed genes (genes with non-zero counts in DESeq2) were calculated which exhibit individual or combinations of differential gene expression (DGE),
differential transcript usage (DTU), and/or alternative splicing (AS) events in the indicated conditions using the respective computational analysis (default
cutoffs are indicated). AS and DTU events were collapsed on the gene level. For DGE, p-values were calculated by DESeq2 using a two-sided Wald test and
corrected for multiple testing using the Benjamini-Hochberg method. For DTU, p-values were calculated by IsoformSwitchAnalyzeR using a DEXSeq-based
test and corrected for multiple testing using the Benjamini-Hochberg method. For AS, p-values were calculated by LeafCutter using an asymptotic
Chi-squared distribution and corrected for multiple testing using the Benjamini-Hochberg method.
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with increasing amounts of NMD targets, e.g., resulting from
reduced transcriptomic fidelity. In line with this idea, previous
attempts to “overload” the NMD machinery by transiently
overexpressing large quantities of NMD substrates did not result
in reduced NMD activity90.
The remarkable capacity of the NMD process is also
reflected in the amount of differentially regulated transcripts that
accumulate in cells with inactive NMD. Earlier studies estimated
that about 5–10% of all human genes are directly or indirectly
influenced by NMD9,12–15. If we consider gene-specific and
isoform-specific effects (differential gene expression, isoform
switches, alternative splicing), we find that between 20 and 40%
of the expressed genes are affected by NMD. These values






















































































































































































































Fig. 5 SMG6 endonucleolytic cleavage is inactivated in SMG5-SMG7 depleted cells. a Schematic overview of the triosephosphate isomerase (TPI)
reporter constructs and their functional elements. The PTC160-containing reporter is subjected to SMG6-mediated endonucleolytic cleavage during NMD.
The resulting decay intermediate (3′ fragment) is rapidly degraded by XRN1, until the presence of an xrRNA blocks the processivity of XRN1, ultimately
resulting in the accumulation of meta-stable xrFrag molecules. b Northern blot analysis of TPI reporter, 3′ fragments (indicated with red triangles), xrFrag,
and 7SL endogenous control. Ethidium bromide-stained 28S and 18S rRNAs are shown as additional controls. Quantification results (normalized to 7SL
control) are shown as data points and mean (n= 3 biologically independent samples). c Schematic depiction of NOP56 maturation and the consequences
of alternative splicing for inducing NMD. Upon inclusion of the snoRD86 sequence in the mature NOP56 mRNA by alternative splice site usage, a PTC is
introduced resulting in endonucleolytic cleavage by SMG6. XRN1-mediated degradation of the decay intermediate is hindered by snoRD86, resulting in the
accumulation of this meta-stable cleavage product. d Northern blot analysis of endogenous NOP56 (n= 3 biologically independent samples). Different
transcript isoforms and fragments are indicated.
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partially explained by using state-of-the-art RNA-sequencing
methods and recent bioinformatic algorithms, allowing a more
thorough analysis of the transcriptomic alterations. Furthermore,
we believe that the SMG7 KO cells in combination with SMG5 or
SMG6 KD result in a more efficient NMD inhibition, which could
not be achieved with previous attempts based on RNA inter-
ference alone. Admittedly, not all of the detected changes in
NMD-incompetent cells are direct effects of NMD inhibition,
since the misregulation of targets such as the splicing factor
SRSF2 will undoubtedly cause secondary effects on the tran-
scriptome. However, the large number of NMD-regulated genes
can explain why NMD is essential for cell survival, proliferation
and differentiation. It is difficult to imagine that important and
fundamental biological processes can function normally when
about one-third of all expressed genes are affected. Given this
large amount of potential cellular NMD substrates, it will be
important in the future to identify and characterize which mRNA
isoforms are authentic NMD-regulated transcripts. This will also
help to better understand the process of NMD and establish
further rules for NMD activating features91.
Our detailed characterization of SMG5 and SMG7 individual
functions revealed interesting and unexpected insights into the
function of these two proteins. Most impressively, the two pro-
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Fig. 6 UPF1 accumulates with NMD factors in SMG5-SMG7 depleted cells. a Overview of the TurboID-mediated proximity labeling of UPF1 binding
partners. Transient UPF1 interactors are marked with biotin via TurboID catalysis. Biotinylated proteins are subsequently enriched with streptavidin beads.
b Western blot and TCE (2,2,2-trichloroethanol)-mediated detection of input or streptavidin-enriched protein samples after proximity labeling in the
indicated conditions (n= 3 biologically independent samples). c Heatmap of mass spectrometry-based analysis of streptavidin-enriched biotinylated
NMD and selected other proteins in the respective comparison of conditions (n= 3 biologically independent samples). Colored points indicate the log2
fold change (log2FC) and point size corresponds to the adjusted p-value (adj. p-value; from two-sided Welch‘s t-test). Multiple testing between FLAG-
TurboID-UPF1 in WT, SMG7 KO, and SMG7 KO+ SMG5 KD was performed by ANOVA. d, e Volcano plots of mass spectrometry-based analysis of
streptavidin-enriched biotinylated proteins in the respective comparison of conditions (n= 3 biologically independent samples). d FLAG-TurboID-UPF1
against FLAG-TurboID control in SMG7 KO cells, (e) FLAG-TurboID-UPF1 against FLAG-TurboID control in SMG7 KO+ SMG5 KD cells. The yellow color
labeling indicates targets that are significant in the respective comparisons after two-sided Welch’s t-testing (log2 fold change (log2FC) >1 or |log2FC| >1;
and adj. p-value <0.05). Points labeled in blue indicate other proteins of interest; points labeled in red indicate NMD factors. Highlighted proteins that were
not significant in the respective comparisons are labeled with gray text.
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SMG7, respectively, rescue the combined SMG5-SMG7 depletion.
The simplest explanation would be that both proteins could form
homodimers in the absence of the heterodimerization partner.
Although not excluded, this possibility does not seem very likely
based on our own preparatory data. Our functional character-
ization established that the main function of SMG5-SMG7 cannot
simply be the recruitment of deadenylation-promoting factors as
was previously proposed64. Also, we could not confirm the direct
recruitment of PP2A phosphatases via the C-terminal PIN
domain of SMG5. Therefore, the overlapping role of SMG5 and
SMG7 during NMD activation probably represents their most
important molecular function. While a single factor (e.g., SMG7)
would presumably be able to execute the same function when
expressed at higher levels, such a system could potentially also
lead to more unwanted NMD activation on barely phosphory-
lated UPF1. Accordingly, SMG5-SMG7 may balance robust
degradation of NMD substrates on the one hand with tight
control of NMD activity on the other.
On a conceptional level, NMD identifies and degrades tran-
scripts that fail to pass quality control standards. To this end, the
NMD pathway makes use of potent cytoplasmic RNA degrada-
tion tools, such as the endonuclease SMG6. However, the access
to and application of this tool must be very tightly controlled to
minimize spurious degradation of normal transcripts. This con-
trol is especially important since NMD probably monitors every
translation termination event and uncontrolled SMG6-mediated
mRNA cleavage would be catastrophic for the cell. Based on our
results, we propose an improved model for the activation of NMD
and attempt to integrate and reconcile earlier observations. In our
opinion, this can best be accomplished with a two-factor
authentication model (Fig. 7a), a security procedure in which
two distinct credentials are required for proper identification. By
analogy, UPF1 represents in our model a surveillance factor,
which has to successfully pass at least two different consecutive
authentication steps on true NMD targets to gain access to
SMG6-mediated activity.
We propose that UPF1 is routinely assigned to control the
quality of all translated mRNAs. It has become increasingly clear
that the mere binding of UPF1 to an mRNA does not trigger its
degradation. However, UPF1 must be removed from the tran-
script in a timely manner to prevent the formation of NMD-
activating complexes. Towards this goal, translating ribosomes
remove most of the RNA-bound UPF1, and only those in the 3’
UTR remain attached to the transcript44–47. Furthermore, effi-
cient and proper translation termination results in the dissocia-
tion of UPF1 from the transcript48.
When translation terminates inefficiently or at aberrant posi-
tions (e.g., upstream of an EJC), this NMD-promoting environ-
ment increases the residence time of UPF1 on the mRNA. At this
point, the first authentication step is installed, which is the pro-
gressive SMG1-mediated phosphorylation of UPF1 (Fig. 7a). It

































Fig. 7 Two-factor authentication model of NMD. a Overview of postulated two-factor authentication model. To grant access to the degradative activities
of NMD, at least two consecutive security checks need to be passed. Aberrant translation termination in combination with an enhanced residence time of
UPF1 on the mRNA and NMD-activating features (e.g., the presence of a downstream EJC) lead to increasing UPF1 phosphorylation by SMG1 (1st
authentication step). Sufficiently phosphorylated UPF1 (p-UPF1) leads to the recruitment of SMG5-SMG7 and consequently enables the endonucleolytic
activity of SMG6 (2nd authentication step). Domains and functions of SMG5 and SMG7 required to support NMD are indicated (green= low importance,
orange=medium, red= high). b Hypothesis for the potential mechanism of the second authentication step. According to this hypothesis, SMG6 can be
bound to p-UPF1 before SMG5-SMG7. The role of SMG5-SMG7 in NMD would be the activation of p-UPF1-bound SMG6.
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UPF1 preferentially in the presence of UPF2, UPF3, and the
EJC50,52,57,58,92. This ensures that UPF1 is only phosphorylated
when bound to positions on the mRNA, where an NMD-
activating arrangement of mRNP features is present. Effectively,
UPF1 remains attached to the (so far only putative) NMD-
transcript and persisting NMD-activating features will cumula-
tively lead to hyper-phosphorylated UPF1 (Fig. 7a).
How is the increasing phosphorylation ultimately converted to
an appropriate mRNA degradation response? We propose, based
on the existing literature and our data, that a second authenti-
cation procedure must be passed to gain access to and/or activate
SMG6 (Fig. 7a). Accordingly, we envision an interaction of
SMG5-SMG7 (individually or as a heterodimer) with phos-
phorylated UPF1 as an essential step to permit efficient SMG6-
mediated endonucleolytic cleavage of the target mRNA. The
evidence supporting this general interpretation is foremost the
robust NMD inhibition in SMG5-SMG7-depleted cells, with no
detectable SMG6-activity (Figs. 2, 4, 5). Furthermore, the tran-
scriptomic changes are highly similar between the loss of the
SMG5-SMG7 heterodimer and the combined SMG7 KO with
SMG6 KD, indicating a similar functional outcome. Further
support for this model comes from the observation that hyper-
phosphorylation alone is not sufficient to induce NMD, as
ATPase-deficient UPF1 mutants are phosphorylated but do not
support NMD42,50,59. Likewise, we also find that globally
increased UPF1 phosphorylation levels do not positively correlate
with NMD activity, as seen in SMG7 KO cells or upon expression
of the SMG5 1-853 mutant (Fig. 3 and Extended Data Fig. 4).
This raises the question about the molecular mechanism
behind the second authentication step and why it depends on
SMG5-SMG7. We initially proposed three hypothetical models
for this second authentication step that could explain the function
of SMG5-SMG7 in NMD. These three models differed foremost
in the way how the access of SMG6 to UPF1 is controlled.
Although SMG6 contains a 14-3-3-like domain and was proposed
to interact directly with UPF1 via phosphorylation-dependent
binding60, a phosphorylation-independent interaction between
SMG6 and UPF1 was reported afterwards63,77,93. If this
phosphorylation-independent SMG6-UPF1 interaction occurred
constantly and was sufficient to activate SMG6-mediated endo-
nucleolytic cleavage, uncontrolled NMD would be observed with
no target discrimination. Since this is not the case, we rather
envision that the binding of SMG5-SMG7 to p-UPF1 could be
required to establish the interaction of SMG6 with UPF1 on
NMD targets. This would fit with the assumption that UPF1
needs to be sufficiently phosphorylated and bound by SMG5-
SMG7 in order to allow SMG6 activity. However, strongly con-
tradicting this hypothesis, we do not observe less, but rather more
SMG6 interaction with UPF1 in SMG5-SMG7-depleted cells.
According to our second hypothesis, catalytically active SMG6
could directly interact with sufficiently phosphorylated UPF1
independently of SMG5-SMG7 and initiate the degradation of the
target mRNA via endonucleolysis. However, the interaction of
SMG5-SMG7 with p-UPF1 would be required to resolve this
NMD-complex and to liberate SMG6 from UPF1. The mechan-
ism could be the displacement of SMG6 from phosphorylated
UPF1 residues by SMG5-SMG7. The absence of SMG5-SMG7 or
their inability to interact with p-UPF1 would lead to dead-end
UPF1-SMG6 complexes that are stuck on cleaved mRNA frag-
ments and cannot engage other NMD targets. Especially con-
sidering the low abundance of SMG6 (Extended Data Fig. 7a),
this would effectively trap SMG6, shut down NMD activity, and
lead to practically undetectable endonucleolytic cleavage, as
observed in our northern blot experiments (Fig. 5).
The last and in our opinion most favorable model is very
similar to the second, except that SMG6 is at first inactive when
bound to p-UPF1 and the subsequent interaction of SMG5-SMG7
with p-UPF1 is required to activate SMG6 (Fig. 7b). According to
this hypothesis, increased interaction of SMG6 with p-UPF1
should occur in SMG5-SMG7-depleted cells, as we have observed
in the UPF1 proximity labeling experiments (Fig. 6). The way in
which SMG5-SMG7 could activate UPF1-bound SMG6 remains
to be investigated in more detail. Possible mechanisms include a
conformational change of UPF1 and/or a switch in the SMG6-
UPF1 binding mode upon binding of SMG5-SMG7. In any case,
according to this hypothesis, SMG6 would remain inactive until
SMG5-SMG7 sensed that UPF1 is sufficiently phosphorylated.
This NMD-routine would ensure that UPF1 remains locked on
transcripts that require further inspection until a decision has
been made to either release the surveillance factor UPF1 or to
degrade the mRNA. Therefore, in the absence of SMG5-SMG7,
UPF1 molecules that engaged NMD authentication would accu-
mulate in unproductive complexes, being unable to dissociate
from the mRNA or to initiate target degradation. Interestingly, we
observe this effect in our TurboID experiment (Fig. 6). When
SMG5 and SMG7 are absent, several NMD factors involved in the
first authentication (e.g., SMG1, SMG8, and SMG9) are biotiny-
lated more by TurboID-UPF1, indicating a stronger interaction
with UPF1 or a longer residence time in the proximity of UPF1.
Whether these enriched NMD factors represent one specific or
more diverse NMD complexes that accumulate on target sub-
strates cannot be conclusively resolved. Since SMG6 seems to also
interact more with UPF1, we speculate that the loss of SMG5-
SMG7 could allow more SMG6 to unproductively bind phos-
phorylated UPF1, which phospho-sites are no longer occupied by
SMG5-SMG7. Although further research would be needed to
formulate a definitive model, we believe that combined aspects
from the three above discussed models may come close to
explaining the essential function of SMG5-SMG7 during NMD.
In conclusion, we present here a revised model for the acti-
vation and execution of NMD. This model is centered around
UPF1 and involves progressive SMG1-mediated phosphorylation
as first, and SMG5-SMG7-mediated activation/recycling of SMG6
as the second authentication step to identify and degrade NMD
targets in a complex transcriptome. The proposed roles of NMD
factors in our model create ample opportunities to investigate
their function and interplay and allows the field to move away
from earlier models, which were based on parallel or redundant
degradation pathways during NMD.
Methods
Cell lines. Flp-In-T-REx-293 (human, female, embryonic kidney, epithelial;
Thermo Fisher Scientific, RRID:CVCL_U427) cells were cultured in high glucose,
GlutaMAX DMEM (Gibco) supplemented with 9% fetal bovine serum (Gibco) and
1 × Penicillin Streptomycin (Gibco). The cells were cultivated at 37 °C and 5% CO2
in a humidified incubator. The generation of knockout and stable cell lines is
described below and all cell lines are summarized in Supplementary Data 6.
Generation of knockout cells using CRISPR-Cas9. The knockouts were per-
formed using the Alt-R CRISPR-Cas9 system (Integrated DNA Technologies) and
reverse transfection of a Cas9:guideRNA ribonucleoprotein complex using Lipo-
fectamine RNAiMAX (Thermo Fisher Scientific) according to the manufacturer’s
protocol. The crRNA sequence (Design ID: Hs.Cas9.SMG7.1.AD; Integrated DNA
Technologies) to target SMG7 was /AlTR1/rGrArArArArUrGrCrUrArGrUrUrAr
CrCrGrArUrUrGrUrUrUrUrArGrArGrCrUrArUrGrCrU/AlTR2/. Reverse trans-
fection was performed on 1.5 × 105 cells per crRNA in 12-well plates. 48 h after
transfection the cells were trypsinized, counted, and seeded at a mean density of a
single cell per well in 96-well plates. Cell colonies originating from a single clone
were then screened via western blot and genome editing of SMG7 was analyzed on
the genomic level via DNA extraction and Sanger sequencing (Eurofins Genomics).
Alterations on the transcript level were analyzed via RNA extraction (see below)
followed by reverse transcription and Sanger sequencing.
DNA and RNA extraction. One day prior to DNA extraction, 2.5 × 105 cells were
seeded in a 6-well plate. To extract DNA, QuickExtract DNA Extraction Solution
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24046-3
14 NATURE COMMUNICATIONS |         (2021) 12:3965 | https://doi.org/10.1038/s41467-021-24046-3 | www.nature.com/naturecommunications
(Lucigen) was used following the manufacturer’s instructions. RNA was isolated
using peqGOLD TriFast (VWR Peqlab) or RNA-Solv (Omega Bio-Tek) following
the manufacturer’s instructions. Following changes were made: Instead of 200 μl
chloroform, 150 μl 1-Bromo-3-chloropropane (Molecular Research Center, Inc.)
was used. RNA was resuspended in 20 μl RNase-free water.
Immunoblot analysis. SDS-polyacrylamide gel electrophoresis and immunoblot
analysis were performed using protein samples harvested with RIPA buffer (50 mM
Tris/HCl pH 8.0, 0.1% SDS, 150 mM NaCl, 1% IGEPAL CA 630, 0.5% deox-
ycholate) or samples eluted from Anti-FLAG M2 magnetic beads (Sigma-Aldrich).
For protein quantification, the Pierce Detergent Compatible Bradford Assay
Reagent (Thermo Fisher Scientific) was used. All antibodies were used at the
indicated dilutions in 50 mM Tris [pH 7.2], 150 mM NaCl with 0.2% Tween-20,
and 5% skim milk powder. Amersham ECL Prime or Select Western Blotting
Detection Reagent (GE Healthcare) in combination with the Fusion FX-6 Edge
system (Vilber Lourmat) was used for visualization. All antibodies used in this
study are listed in Supplementary Data 6. Protein bands detected with the Fusion
FX-6 Edge system (Vilber Lourmat) using the Evolution-Capt Edge software
(version 18.05) were quantified in a semi-automated manner using the Image-
Quant TL 1D software (version 8.1) with a rolling-ball background correction. The
control condition was set to unity, quantification results are shown as data points
and mean.
Growth assay. To measure the growth and mortality rate of cells, CytoTox-Glo
Cytotoxicity Assay (Promega) was performed. 10,000 cells/well were seeded in a
96-well plate and the assay was performed after 0–4 days using luminometer
Centro XS3 LB 960 (Berthold Technologies) and the MikroWin software (version
5.14) following the manufacturer’s instructions.
Stable cell lines and plasmids. The point and deletion mutants of SMG7 were
PCR amplified using Q5 polymerase (New England Biolabs) and inserted with an
N-terminal FLAG-tag via NheI and NotI (both New England Biolabs) restriction
sites into PB-CuO-MCS-IRES-GFP-EF1α-CymR-Puro (System Biosciences).
Accordingly, N-terminally FLAG-tagged GST or UPF1, as well as FLAG-TurboID
or FLAG-TurboID-UPF1 (generated with Integrated DNA Technologies gBlocks
and/or PCR amplification) were cloned via NheI and NotI into PB-CuO-MCS-
BGH-EF1-CymR-Puro, which was modified from the original vector by replacing
the IRES-GFP cassette with a BGH polyA signal.
The point and deletion mutants of SMG5 were PCR amplified using Q5
polymerase and inserted with an N-terminal FLAG-tag via NheI and NotI
restriction sites into the tetracycline-inducible pcDNA5/FRT/TO vector (Thermo
Fisher Scientific). The mRNA reporter constructs TPI-WT and TPI-PTC160 in the
pcDNA5/FRT/TO vector are available on Addgene (IDs 108377-108378).
The cells were stably transfected using the PiggyBac Transposon system (SMG7,
UPF1, GST) or using the Flp-In T-REx system (SMG5, mRNA reporter). 2.5–3 ×
105 cells were seeded 24 h before transfection in 6-wells. For PiggyBac stable cells,
2 µg of PiggyBac construct was transfected together with 0.8 µg of the Super
PiggyBac Transposase expressing vector and for Flp-In T-REx stable cells, 1-2 µg of
pcDNA5 construct was transfected together with 1 µg of the Flp recombinase
expressing plasmid pOG44, using the calcium phosphate method. Forty-eight
hours after transfection, the cells were transferred into 10 cm dishes and selected
with 2 µg ml−1 puromycin (InvivoGen) for PiggyBac or 100 µg ml−1 hygromycin
(InvivoGen) for Flp-In T-REx. After 7–10 days, the colonies were pooled.
Expression of the PiggyBac constructs was induced with 30 µg ml−1 cumate, Flp-In
T-REx constructs were induced with 1 µg ml−1 doxycycline. All vectors used in this
study are listed in Supplementary Data 6.
Mycoplasma contamination was tested by PCR amplification of mycoplasma-
specific genomic DNA94 or by using the Mycoplasmacheck service (Eurofins
Genomics).
Reverse transcription, end-point, and quantitative RT-PCR. 1–4 µg of total
RNA was reverse-transcribed in a 20 µl reaction volume with 10 µM VNN-(dT)20
primer using the GoScript Reverse Transcriptase (Promega). 2% of cDNA was used
as template in end-point PCRs using the GoTaq Green Master Mix (Promega) or
MyTaq Red Mix (Bioline) and 0.2–0.6 µM final concentration of sense and anti-
sense primer (see Supplementary Data 6 for sequences). After 30 PCR cycles, the
samples were resolved by electrophoresis on ethidium bromide-stained, 1–2%
agarose TBE gels and visualized by trans-UV illumination using the Gel Doc XR+
(Bio-Rad) and Image Lab software (version 5.1).
Bands detected in agarose gels from the indicated biological replicates of end-
point PCRs were quantified using the Image Lab software (version 6.0.1). Results of
the indicated band % per lane are shown as data points and mean. Sanger
sequencing of individual bands was performed using the service of Eurofins
Genomics.
Quantitative RT-PCR was performed with the GoTaq qPCR Master Mix
(Promega) using 2% of cDNA in 10 µl reactions, 0.2–0.6 µM final concentration of
sense and antisense primer (see Supplementary Data 6 for sequences), and the
CFX96 Touch Real-Time PCR Detection System (Bio-Rad) with Bio-Rad CFX
Manager software (version 3.0). The reactions for each biological replicate were
performed in duplicates or triplicates and the average Ct (threshold cycle) value
was measured. For alternative splicing events, values for canonical isoforms were
subtracted from values for NMD-sensitive isoforms to calculate the ΔCt. For
differentially expressed targets, the values for the housekeeping genes C1orf43 were
subtracted from values for the target to calculate the ΔCt. The mean log2 fold
changes were calculated from three biologically independent experiments. Log2
fold change results are shown as data points and mean.
siRNA-mediated knockdowns. Cells were seeded in 6-well plates at a density of
2–3 × 105 cells per well and reverse transfected using 2.5 µl Lipofectamine RNAi-
MAX and 60 pmol of the respective siRNA(s) according to the manufacturer’s
instructions. In preparation for UPF1 phosphorylation and RNA immunopreci-
pitation (RIP) assays, 3 × 106 cells were reverse transfected in 10 cm dishes using
6.25 µl Lipofectamine RNAiMAX and 150–200 pmol siRNA. All siRNAs used in
this study are listed in Supplementary Data 6.
RNA-sequencing and computational analyses. RNA-Seq experiments were
carried out with Flp-In-T-REx-293 wild-type (WT) cells transfected with Luciferase
or SMG5 siRNA and the SMG7 KO clones 2 and 34 transfected with either
Luciferase, SMG5, or SMG6 siRNAs. Three biological replicates were analyzed for
each sample. Total RNA was extracted using peqGOLD TriFast (VWR Peqlab) as
described above.
The Lexogen SIRV Set1 Spike-In Control Mix (SKU: 025.03) that provides a set
of external RNA controls was added to the total RNA to enable performance
assessment. Mix E0 was added to samples with Luciferase siRNA, mix E1 was
added to samples with SMG5 siRNA, and mix E2 samples with SMG6 siRNA. The
Spike-Ins were used for quality control purposes, but not used for the final analysis
of DGE, DTU, or AS.
The library preparation was performed with the TruSeq mRNA Stranded kit
(Illumina). After poly-A selection (using poly-T oligo-attached magnetic beads),
mRNA was purified and fragmented using divalent cations under elevated
temperatures. The RNA fragments underwent reverse transcription using random
primers. This is followed by second-strand cDNA synthesis with DNA Polymerase
I and RNase H. After end repair and A-tailing, indexing adapters were ligated. The
products were then purified and amplified to create the final cDNA libraries. After
library validation and quantification (Agilent tape station), equimolar amounts of
the library were pooled. The pool was quantified by using the Peqlab KAPA Library
Quantification Kit and the Applied Biosystems 7900HT Sequence Detection
System and sequenced on an Illumina NovaSeq6000 sequencing instrument and a
PE100 protocol.
Reads were aligned against the human genome (version 38, GENCODE release
33 transcript annotations95 supplemented with SIRVomeERCCome annotations
from Lexogen; obtained from https://www.lexogen.com/sirvs/download/) using the
STAR read aligner (version 2.7.3a)96. Transcript abundance estimates were
computed with Salmon (version 1.3.0)97 with a decoy-aware transcriptome. After
the import of transcript abundances, differential gene expression analysis was
performed with the DESeq298 R package (version 1.28.1) with the significance
thresholds |log2FoldChange|> 1 and adjusted p-value (padj) <0.05. Differential
splicing was detected with LeafCutter (version 0.2.9)99 with the significance
thresholds |deltapsi| >0.1 and adjusted p-value (p.adjust) <0.05. Differential
transcript usage was computed with IsoformSwitchAnalyzeR (version 1.10.0) and
the DEXSeq method75,100–104. Significance thresholds were |dIF| >0.1 and adjusted
p-value (isoform_switch_q_value) <0.05.
PTC status of transcript isoforms with the annotated open reading frame was
determined by IsoformSwitchAnalyzeR using the 50 nucleotides (nt) rule of
NMD75,105–107. Isoforms with no annotated open reading frame in GENCODE
were designated “NA” in the PTC analysis.
The control, SMG7, and SMG6/7 knockdown datasets (Gene Expression
Omnibus, GEO: GSE86148)14 were processed and analyzed with the same
programs, program versions, and scripts as the SMG7 KO dataset, with minor
changes due to the different sequencing method (paired-end vs. single-end). All
scripts and parameters for the RNA-Seq analysis are available at GitHub [https://
github.com/boehmv/SMG5-SMG7]. Overlaps of data sets were represented via
nVenn108 or the ComplexHeatmap package (version 2.6.2)109. Integrative
Genomics Viewer (IGV) (version 2.8.12)110 snapshots were generated from
mapped reads (BAM files) converted to binary tiled data (tdf), using Alfred111 with
resolution set to 1 and IGVtools. Mean junction counts were obtained from
sashimi plots generated using ggsashimi112.
Protein structure modeling and visualization. The structure of human SMG7
(PDB: 1YA0) was superimposed onto the C. elegans SMG7 (PDB: 3ZHE) using the
MatchMaker command in Chimera version 1.13113, to generate a hsSMG7-
ceSMG5 hybrid model. ChimeraX version 1.0114 was used to visualize the modeled
structure.
Northern blotting. The cells were harvested in peqGOLD TriFast reagent (VWR)
and total RNA extraction was performed as described above. 2–4 μg of total RNA
were resolved on a 1% agarose/0.4 M formaldehyde gel using the tricine/trietha-
nolamine buffer system115 followed by a transfer on a nylon membrane (Roth) in
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10× SSC. The blots were incubated overnight at 65 °C in Church buffer containing
α-32P-GTP [800 Ci/mmol, 10 mCi/ml] body-labeled RNA probes for detection of
the reporter mRNA80.
Endogenous 7SL RNA was detected by a 5′-32P-labeled oligonucleotide (5′-TG
CTCCGTTTCCGACCTGGGCCGGTTCACCCCTCCTT-3′) for which γ-32P-
ATP [800 Ci/mmol, 10 mCi/ml] was used for labeling. For NOP56 northern blots,
the ex8b riboprobe sequence (5′-GAAACUUGGUCCCUUUGCUGGGCCCUGG
GAAUCACUCAGACACCAGGACUGGCCAUCACCCCCAUAGCAGAGGCC
UGUAUAGGUCAGGGAGCCCUGGUCAGCCAUCACCGUGAUCCCCCAAC
AAGCAGUGGGCACCAGAAGUGGCACCUGAUU-3′)81 was cloned into the
pSP73 vector, linearized and in vitro transcribed using α-32P-GTP [3000 Ci/mmol,
10 mCi/ml]. Ethidium bromide-stained 28S and 18S rRNA served as loading
controls. RNA signal from at least three distinct samples was detected with the
Typhoon FLA 7000 (GE Healthcare) and was quantified in a semi-automated
manner using the ImageQuant TL 1D software (version 8.1) with a rolling-ball
background correction. EtBr-stained rRNA bands were quantified with the Image
Lab 6.0.1 software (Bio-Rad). Signal intensities were normalized to the internal
control (7SL or rRNA) before the calculation of mean values. The control condition
was set to unity (TPI WT for reporter assays), quantification results are shown as
data points and mean.
RNA immunoprecipitation (RIP). The RIP protocol was adapted from Lee et al.48.
Two days after seeding and reverse transfecting cells with siRNA, the cells were
washed with 2 ml PBS, harvested in 1 ml PBS, collected for 10 min at 100 × g, and
resuspended in 300 µl RIP lysis buffer (10 mM Tris pH 7.5, 150 mM NaCl, 2 mM
EDTA, 0.1% Triton X-100) supplemented with 1 tablet of PhosSTOP (Roche),
100 µl EDTA-free HALT Protease and Phosphatase Inhibitor (ThermoFisher) and
20 µl RNasin (Promega) per 10 ml buffer. Protein concentration was measured,
adjusted to 1 mg total protein in 450 µl RIP buffer, 20 µl of the sample was added to
500 µl peqGOLD TriFast and saved as input sample. The remaining sample was
divided into 2× 200 µl and combined with 30 µl pre-washed Dynabeads Protein G
beads (ThermoFisher), which were pre-incubated with 5 µg of either purified goat
IgG (control; Bethyl, P50-100) or UPF1 antibody (Bethyl, A300-036A). The sam-
ples were incubated in an overhead rotator for 1 h at 4 °C, washed 5× with 1 ml RIP
Wash Buffer (5 mM Tris pH 7.5, 150 mM NaCl, 0.1% Triton X-100), and co-
immunoprecipitated RNA was recovered by incubating the beads with 500 µl RNA-
solv. for 10 min at room temperature. Both input and IP samples were subjected to
RNA extraction with the addition of 1 µl Precipitation Carrier. Ten microliters of
resuspended RNA were used for reverse transcription and 2% of cDNA was used
for quantitative PCR.
Co-immunoprecipitation. FLAG-tagged proteins were expressed in stable cell lines
(2.5–3.0 × 106 cells per 10 cm dish) induced for 48–72 h. The samples were lysed in
600 µl buffer E (20 mM HEPES-KOH (pH 7.9), 100 mM KCl, 10% glycerol, 1 mM
DTT, Protease Inhibitor, 1 µg ml−1 RNase A) and sonicated using the Bandelin
Sonopuls mini20 with 15 pulses (2.5 mm tip, 1 s pulse, 50% amplitude).
Concentration-adjusted lysates were subjected to immunoprecipitation for 2 h at
4 °C with overhead shaking using Anti-FLAG M2 Magnetic Beads (Sigma-Aldrich),
the beads were washed three times for 5 min with buffer E, mild wash buffer
(20 mM HEPES-KOH (pH 7.9), 137 mM NaCl, 2 mM MgCl2, 0.2% Triton X-100,
0.1% NP-40) or medium wash buffer (20 mM HEPES-KOH (pH 7.9), 200 mM
NaCl, 2 mM MgCl2, 0.2% Triton X-100, 0.1% NP-40, 0.05% Na-deoxycholate). Co-
immunoprecipitated proteins were eluted with SDS-sample buffer, separated by
SDS-PAGE, and analyzed by immunoblotting.
Label-free quantitative mass spectrometry. FLAG-tagged SMG5 proteins or
FLAG control were expressed in stable cell lines (2.5–3.0 × 106 cells per 10 cm dish)
induced with 1 µg ml−1 doxycycline for 72 h. Samples were lysed and immuno-
precipitated as described above, using mild wash buffer for washing steps and
eluted in 42.5 µl of a 200 mg ml−1 dilution of FLAG peptides (Sigma) in 1× TBS. 1
volume of 10% SDS was added and the samples were reduced with DTT and
alkylated with CAA (final concentrations 5 mM and 55 mM, respectively). Tryptic
protein digestion was performed using a modified version of the single pot solid
phase-enhanced sample preparation (SP3)116. In brief, reduced and alkylated
proteins were supplemented with paramagnetic Sera-Mag speed beads (Thermo
Fisher Scientific) and mixed in a 1:1-ratio with 100% acetonitrile (ACN). After
8 min incubation protein-beads-complexes were captured using an in-house build
magnetic rack and two times washed with 70% EtOH. Afterward, samples were
washed once with 100% ACN, air-dried and reconstituted in 5 µl 50 mM Trie-
thylammonium bicarbonate supplemented with 0.5 µg trypsin and 0.5 µg LysC and
incubated overnight at 37 °C. On the next day, the beads were resuspended and
mixed with 200 µl ACN, incubated for 8 min, and again placed on the magnetic
rack. Tryptic peptides were washed once with 100% ACN, airdried, dissolved in 4%
DMSO, and transferred into 96-well PCR tubes. After acidification with 1 µl of 10%
formic acid, the samples were ready for LC-MS/MS analysis.
Proteomics analysis was performed by data-dependent acquisition using an
Easy nLC1000 ultra-high-performance liquid chromatography (UHPLC) system
coupled via nanoelectrospray ionization to a Q Exactive Plus instrument (all
Thermo Scientific). Tryptic peptides were separated based on their hydrophobicity
using a chromatographic gradient of 45 min (affinity enrichments samples) or
60 min (TurboID samples) with a binary system of buffer A (0.1% formic acid) and
buffer B (80% ACN, 0.1% formic acid). In-house-made analytical columns (length:
50 cm, inner diameter: 75 µm) filled with 1.9 µm C18-AQ Reprosil Pur beads (Dr.
Maisch) were used for separation. Using the 45 min chromatographic gradient,
buffer B was linearly increased from 9 to 30% over 30 min followed by a steeper
increase to 47% within 6 min. Finally, buffer B was increased to 95% within 4 min
and stayed at 95% for 5 min to wash the analytical column. For the 60 min
chromatographic gradient, buffer B was linearly increased from 3 to 30% over
40 min followed by an increase to 50% within 8 min. Finally, buffer B was increased
to 95% within 1 min and the column washed for 10 at 95%. Full MS spectra
(300–1750 m/z) were acquired with a resolution of 70,000, a maximum injection
time of 20 ms, and an AGC target of 3e6. The top 10 most abundant peptide ions of
each full MS spectrum were selected for HCD fragmentation (NCE: 26) with an
isolation width of 1.8 m/z and a dynamic exclusion of 20 s. MS/MS spectra were
measured with a resolution of 17,000, a maximum injection time of 60 ms and an
AGC target of 5e5 for the 45 min gradient, and a resolution of 35,000, a max.
injection time of 110 ms and an AGC target of 5e5 using the 60 min gradient.
MS RAW files were analyzed using the standard settings of the MaxQuant suite
(version 1.6.17.0)117. Peptides were identified by matching against the human
UniProt database using the Andromeda scoring algorithm118.
Carbamidomethylation of cysteine was set as a fixed modification, methionine
oxidation, and N-terminal acetylation as variable modification. Trypsin/P was
selected as the digestion protein. A false discovery rate (FDR) <0.01 was used for
the identification of peptide-spectrum matches and protein quantification.
Intensities were calculated using the LFQ algorithm implemented in MaxQuant
with the standard parameters. Data processing and statistical analysis were done in
the Perseus software (version 1.6.5.0)119. LFQ-normalized protein intensities were
Log2-transformed for normal distribution and filtered for at least three valid values
in at least one sample group. Missing values were imputed by drawing random
values from a 1.8 standard deviations downshifted, 0.3 standard deviations broad
normal distribution. Statistical testing was performed using a two-sided Welch’s t-
test with permutation-based FDR correction (FDR= 0.05, S0= 0.1). Significantly
different proteins were identified using the following cut-off: q-value <0.05,
absolute log2 fold change >1. Visualization was performed with InstantClue120, the
R (version 4.0.4) package ggplot2 (version 3.3.3) or ComplexHeatmap (version
2.6.2)109.
TurboID proximity labeling. Stable WT or SMG7 KO cell lines were seeded (5 × 106
cells per 10 cm dish) and reverse transfected using 6.25 µl Lipofectamine RNAiMAX
and 200 pmol siRNA (control or SMG5). The expression of FLAG-TurboID-tagged
UPF1 or control proteins was induced on the next day with 30 µg ml−1 cumate. In
this step the medium was also changed to high-glucose, GlutaMAX DMEM (Gibco)
supplemented with 9% dialyzed fetal bovine serum (Gibco; A3382001; to suppress
background biotinylation)121 and 1× Penicillin Streptomycin (Gibco). Proximity
labeling by biotinylation was performed on the next day by the addition of 50 µM
biotin for 15min. Afterward, the cells were washed twice with PBS on ice, scraped in
1ml ice-cold PBS, collected for 5min at 100 × g and 4 °C, and finally resuspended in
200 µl phospho-RIPA buffer (50mM Tris pH 8.0, 150mM NaCl, 1% IGEPAL CA-
630, 0.5% deoxycholate, 0.1% SDS, 1 µg ml−1 RNase A) supplemented with 1 tablet of
PhosSTOP (Roche), 100 µl EDTA-free HALT Protease and Phosphatase Inhibitor
(ThermoFisher) and per 10ml buffer. Samples were sonicated using the Bandelin
Sonopuls mini20 with 10 pulses (2.5 mm tip, 1 s pulse, 50% amplitude). Fifty
microliter input aliquots containing 100 µg of total protein were prepared and mixed
with SDS-sample buffer. Concentration-adjusted lysates containing 1mg total protein
in 500 µl buffer were concentrated to approximately 100 µl in 0.5 ml Amicon Ultra
centrifugal filter devices (3K cutoff) for 45min at 4 °C and 14.000 × g, to minimize
excess biotin in the sample. The concentrated sample was combined with 200 µl RIPA
buffer (wash of centrifugal filter), mixed with 25 µl pre-washed Pierce Streptavidin
Magnetic Beads (ThermoFisher), and incubated for 2 h at 4 °C with overhead shaking.
The beads were washed four times for 5 min with 800 µl RIPA buffer, followed by one
wash with 800 µl mild wash buffer (20mM HEPES-KOH (pH 7.9), 137mM NaCl,
2 mM MgCl2, 0.2% Triton X-100, 0.1% NP-40). Biotinylated proteins were eluted
with 50 µl 1× SDS-sample buffer, supplemented with 20 mM DTT and 3mM biotin,
for 15min at 96 °C, followed by another elution with 25 µl and both eluates were
combined. Aliquots (10 µl input, 12.5 µl eluate) of the samples were resolved on 10%
polyacrylamide gels containing 25 µl TCE (2,2,2-trichloroethanol) to allow fluorescent
visible detection of proteins122 and subsequently used for western blotting. Tryptic
protein digestion and proteomics analysis were performed as described above. Of
note, no SMG5 Label-Free Quantification (LFQ) intensities were obtained, although
SMG5 peptides were only detected in the WT samples and not in the SMG7 KO.
Data presentation. Quantifications and calculations for other experiments were
performed—if not indicated otherwise—with Microsoft Excel (version 1808) or R
(version 4.0.4) and all plots were generated using IGV (version 2.8.12), GraphPad
Prism 5, ggplot2 (version 3.3.3), or ComplexHeatmap (version 2.6.2). Boxplots
were generated using the geom_boxplot() function of ggplot2 with the centerline
representing the 50th percentile (median), whereas the lower and upper box limits
correspond to the 25th and 75th percentiles. The whiskers extend from the box
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limits to the smallest or largest value no further than 1.5 * inter-quartile range.
Data beyond the end of the whiskers are plotted individually.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
RNA-sequencing data generated for this manuscript have been deposited in the
ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress)123 under accession
number E-MTAB-9330. Published datasets analyzed for this paper include Gene
Expression Omnibus (GEO) accession number GSE86148. Data of human proteome
abundances were retrieved from https://proteomesoflife.org/ with the human taxonomy
identifier (9606) on 2021-03-03 (03. March 2021)89. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Consortium via the PRIDE124 partner
repository with the dataset identifier PXD024747. Published protein structures were
human SMG7 (PDB: 1YA0 [https://doi.org/10.2210/pdb1YA0/pdb) and C. elegans
SMG5-SMG7 (PDB: 3ZHE [https://doi.org/10.2210/pdb3ZHE/pdb]). All relevant data
supporting the key findings of this study are available within the article and its
Supplementary Information files or from the corresponding author upon reasonable
request. Source data—where applicable—are provided for all figures, including raw
images of EtBr-stained agarose gels, western blots, and northern blots, as well as qPCR
raw values, quantification, and an overview file stating all further necessary information
(e.g., which antibody was used). All raw source data can also be accessed at Zenodo
[https://doi.org/10.5281/zenodo.4603278]. Source data are provided with this paper.
Code availability
The codes used in this study are available at GitHub (https://github.com/boehmv/SMG5-
SMG7) and Zenodo (https://doi.org/10.5281/zenodo.4603388).
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